All About Multiple Sclerosis

More MS news articles for November 2002

Interleukin 23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin 17

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12417590&dopt=Abstract

Free Full Text at:
http://www.jbc.org/cgi/reprint/M207577200v1.pdf

J Biol Chem 2002 Nov 3
Aggarwal S, Ghilardi N, Xie MH, De Sauvage FJ, Gurney AL.
Department of Molecular Biology, Genentech Inc., San Francisco, CA 94080.

Interleukin-17 is a proinflammatory cytokine that is produced by activated T cells.

Despite increasing evidence that high levels of IL-17 are associated with several chronic inflammatory diseases including rheumatoid arthritis, psoriasis and multiple sclerosis, the regulation of its expression is not well characterized.

We observe that IL-17 production is increased in response to the recently described cytokine IL-23.

We present evidence that murine IL-23, which is produced by activated dendritic cells, acts on memory T cells, resulting in elevated IL-17 secretion.

IL-23 also induced expression of the related cytokine IL-17F.

IL-23 is a heterodimeric cytokine and shares a subunit, p40, with IL-12.

In contrast to IL-23, IL-12 had only marginal effects on IL-17 production.

These data suggest that during a secondary immune response, IL-23 can promote an activation state with features distinct from the well characterized Th1, and Th2 profiles.